Adjuvants: Classification, Modus Operandi, and Licensing

JS Apostolico, VAS Lunardelli… - Journal of …, 2016 - Wiley Online Library
Vaccination is one of the most efficient strategies for the prevention of infectious diseases.
Although safer, subunit vaccines are poorly immunogenic and for this reason the use of …

CpG DNA as a vaccine adjuvant

C Bode, G Zhao, F Steinhagen, T Kinjo… - Expert review of …, 2011 - Taylor & Francis
Synthetic oligodeoxynucleotides (ODNs) containing unmethylated CpG motifs trigger cells
that express Toll-like receptor 9 (including human plasmacytoid dendritic cells and B cells) …

A regulatory feedback between plasmacytoid dendritic cells and regulatory B cells is aberrant in systemic lupus erythematosus

M Menon, PA Blair, DA Isenberg, C Mauri - Immunity, 2016 - cell.com
Signals controlling the generation of regulatory B (Breg) cells remain ill-defined. Here we
report an" auto"-regulatory feedback mechanism between plasmacytoid dendritic cells …

Nucleic acid immunity

G Hartmann - Advances in immunology, 2017 - Elsevier
Organisms throughout biology need to maintain the integrity of their genome. From bacteria
to vertebrates, life has established sophisticated mechanisms to detect and eliminate foreign …

Therapeutic potential of Toll-like receptor 9 activation

AM Krieg - Nature reviews Drug discovery, 2006 - nature.com
In the decade since the discovery that mouse B cells respond to certain unmethylated CpG
dinucleotides in bacterial DNA, a specific receptor for these'CpG motifs' has been identified …

Toll-like receptor 9 agonists in cancer

L Karapetyan, JJ Luke, D Davar - OncoTargets and therapy, 2020 - Taylor & Francis
Abstract Toll-like receptor 9 (TLR9) is a pattern recognition receptor that is predominantly
located intracellularly in immune cells, including dendritic cells, macrophages, natural killer …

Clinical evaluation of CpG oligonucleotides as adjuvants for vaccines targeting infectious diseases and cancer

J Scheiermann, DM Klinman - Vaccine, 2014 - Elsevier
Synthetic oligonucleotides (ODN) that express unmethylated “CpG motifs” trigger cells that
express Toll-like receptor 9. In humans this includes plasmacytoid dendritic cells and B cells …

Immunotherapeutic uses of CpG oligodeoxynucleotides

DM Klinman - Nature Reviews Immunology, 2004 - nature.com
Synthetic oligodeoxynucleotides (ODNs) that contain immunostimulatory CpG motifs trigger
an immunomodulatory cascade that involves B and T cells, natural killer cells and …

Toll-like receptors in systemic autoimmune disease

A Marshak-Rothstein - Nature Reviews Immunology, 2006 - nature.com
Toll-like receptors (TLRs) have a crucial role in the early detection of pathogen-associated
molecular patterns and the subsequent activation of the adaptive immune response …

Toll-Like Receptor 8-Mediated Reversal of CD4+ Regulatory T Cell Function

G Peng, Z Guo, Y Kiniwa, KS Voo, W Peng, T Fu… - Science, 2005 - science.org
CD4+ regulatory T (Treg) cells have a profound ability to suppress host immune responses,
yet little is understood about how these cells are regulated. We describe a mechanism …